These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 349800)

  • 81. Factors responsible for the differential survival of heart and skin allografts in inbred rats.
    Warren RP; Lofgreen JS; Steinmuller D
    Transplantation; 1973 Nov; 16(5):458-65. PubMed ID: 4584955
    [No Abstract]   [Full Text] [Related]  

  • 82. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Onodera K; Schaub M; Korom S; Binder J; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):1016. PubMed ID: 9123176
    [No Abstract]   [Full Text] [Related]  

  • 83. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract]   [Full Text] [Related]  

  • 84. Transplantation unresponsiveness induced by allogeneic serum in combination with allogeneic cells and hydrocortisone in adult rats.
    Hasek M; Chutná J; Holán V
    Transplantation; 1978 Feb; 25(2):53-5. PubMed ID: 341426
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cellular mechanisms underlying differential rejection of sequential heart and lung allografts in rats.
    Moller F; Hoyt G; Farfan F; Starnes VA; Clayberger C
    Transplantation; 1993 Mar; 55(3):650-5. PubMed ID: 8456486
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The effect of lentil lectin treatment on the survival of rat skin allografts in strain combinations with different genetic disparity.
    Hilgert I; Kristofová H; Kren V; Panczak A
    Folia Biol (Praha); 1984; 30(2):104-8. PubMed ID: 6373390
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Production of indefinite renal allograft survival in the rat by pretreatment with viable and nonviable hepatocytes or liver membrane extracts.
    Foster S; Cranston D; Wood KJ; Morris PJ
    Transplantation; 1988 Jan; 45(1):228-31. PubMed ID: 3276051
    [No Abstract]   [Full Text] [Related]  

  • 88. The major histocompatibility system (MHS) in man.
    Morris PJ
    Prog Biophys Mol Biol; 1975; 30(1):83-97. PubMed ID: 1101298
    [No Abstract]   [Full Text] [Related]  

  • 89. Failure to confirm the influence of splenectomy on the survival of H-Y-incompatible skin grafts in mice.
    Berryman PL; Silvers WK
    Transplantation; 1979 Apr; 27(4):287-8. PubMed ID: 375506
    [No Abstract]   [Full Text] [Related]  

  • 90. The influence of histocompatibility and transplant site on parathyroid allograft survival.
    Naji A; Barker CF
    J Surg Res; 1976 Apr; 20(4):261-7. PubMed ID: 933479
    [No Abstract]   [Full Text] [Related]  

  • 91. Failure of concanavlain A perfusion to prolong kidney allograft survival in rats.
    Numata M; Sutherland DE; Payne WD; Najarian JS; Simmons RL
    Transplantation; 1978 Jun; 25(6):339-40. PubMed ID: 351893
    [No Abstract]   [Full Text] [Related]  

  • 92. Comparison of end-to-end and telescoped arterial anastomoses in renal transplantation in rats.
    Choi HK; Stowe N; Novick AC
    J Microsurg; 1981; 3(2):85-8. PubMed ID: 7047669
    [No Abstract]   [Full Text] [Related]  

  • 93. Immunogenicity of allograft components. II. Relative immunogenicity of rat kidney parenchymal versus "passenger" cells.
    Parthenais E; Soots A; Nemlander A; von Willebrand E; Häyry P
    Cell Immunol; 1981 Jan; 57(1):92-8. PubMed ID: 6260383
    [No Abstract]   [Full Text] [Related]  

  • 94. The influence of the major histocompatibility complex on liver allograft survival in the pig.
    Vailman M; Bacourt F; Villiers PA; Garnier H
    Transplantation; 1976 Oct; 22(4):402-4. PubMed ID: 790696
    [No Abstract]   [Full Text] [Related]  

  • 95. [Allogeneic kidney transplantation in the rat].
    Xia SH; Chen JZ
    Acta Acad Med Wuhan; 1981; 1(2):24-9. PubMed ID: 6762511
    [No Abstract]   [Full Text] [Related]  

  • 96. The genetic divergence of sublines as assessed by histocompatibility testing.
    Silvers WK; Gasser DL
    Genetics; 1973 Dec; 75(4):671-7. PubMed ID: 4591657
    [TBL] [Abstract][Full Text] [Related]  

  • 97. An Ly-like specificity with extensive nonlymphoid expression.
    Halloran PF; Dutton D; Chance H; Cohen Z
    Immunogenetics; 1978 Dec; 7(1):185-200. PubMed ID: 21302074
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Non-major histocompatibility system immunogenetic influences in rat renal allograft survival.
    Paris AM; Bishop C; Festenstein H; Gunther E
    Transplantation; 1978 May; 25(5):252-4. PubMed ID: 349800
    [TBL] [Abstract][Full Text] [Related]  

  • 99. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The immunogenetic influence of non-MSH systems on rat renal allograft survival.
    Bishop CE; Paris AM; Festenstein H; Günther E
    Transplant Proc; 1979 Jun; 11(2):1351-2. PubMed ID: 382519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.